Amicus Therapeutics, Inc. financial data

Symbol
FOLD on Nasdaq
Industry
Pharmaceutical Preparations
Location
3675 Market Street, Philadelphia, PA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 284 % -0.37%
Quick Ratio 40 % +108%
Debt-to-equity 441 % -15.2%
Return On Equity -85.9 % +45.6%
Return On Assets -15.9 % +37.6%
Operating Margin -7.35 % +80.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 297M shares +3.3%
Common Stock, Shares, Outstanding 296M shares +3.29%
Entity Public Float 3.56B USD +19.4%
Common Stock, Value, Issued 2.92M USD +2.35%
Weighted Average Number of Shares Outstanding, Basic 304M shares +3.75%
Weighted Average Number of Shares Outstanding, Diluted 304M shares +3.75%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 456M USD +30%
Operating Income (Loss) -33.5M USD +74.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -140M USD +34.3%
Income Tax Expense (Benefit) 19.7M USD +482%
Net Income (Loss) Attributable to Parent -120M USD +35.5%
Earnings Per Share, Basic -0.39 USD/shares +39.1%
Earnings Per Share, Diluted -0.39 USD/shares +39.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 209M USD -0.93%
Marketable Securities, Current 50.7M USD -6.61%
Accounts Receivable, after Allowance for Credit Loss, Current 85.2M USD +33.7%
Inventory, Net 81.3M USD +58.3%
Assets, Current 462M USD +6.67%
Property, Plant and Equipment, Net 31.2M USD +3.05%
Operating Lease, Right-of-Use Asset 22.6M USD -19.4%
Intangible Assets, Net (Excluding Goodwill) 18.9M USD -14.9%
Goodwill 198M USD 0%
Other Assets, Noncurrent 17.4M USD -8.86%
Assets 749M USD +2.66%
Accounts Payable, Current 32.1M USD +137%
Employee-related Liabilities, Current 38.3M USD +49%
Liabilities, Current 168M USD +5.55%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 47M USD -7.79%
Other Liabilities, Noncurrent 12.9M USD +43.2%
Liabilities 617M USD -0.25%
Retained Earnings (Accumulated Deficit) -2.75B USD -4.55%
Stockholders' Equity Attributable to Parent 133M USD +18.8%
Liabilities and Equity 749M USD +2.66%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.7M USD -64.3%
Net Cash Provided by (Used in) Financing Activities -13.3M USD -70.1%
Net Cash Provided by (Used in) Investing Activities 7.54M USD -79.2%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 296M shares +3.29%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -37.3M USD -414%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 212M USD -0.92%
Interest Paid, Excluding Capitalized Interest, Operating Activities 11.8M USD +3.87%
Deferred Tax Assets, Valuation Allowance 649M USD +2.69%
Deferred Tax Assets, Gross 659M USD -6.83%
Operating Lease, Liability 57.2M USD -4.87%
Payments to Acquire Property, Plant, and Equipment 1.81M USD -6.75%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -115M USD +29.9%
Lessee, Operating Lease, Liability, to be Paid 89.8M USD -46.8%
Property, Plant and Equipment, Gross 57.1M USD +7.61%
Operating Lease, Liability, Current 8.11M USD +3.47%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.16M USD +6.18%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.24M USD -2.43%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure -16.4%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.3M USD -88.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.21M USD +9.43%
Deferred Tax Assets, Operating Loss Carryforwards 321M USD +1.76%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.35M USD +9.1%
Amortization of Intangible Assets 800K USD
Depreciation, Depletion and Amortization 8.75M USD +44.3%
Share-based Payment Arrangement, Expense 81.6M USD -3.85%
Interest Expense 50.7M USD +24.3%